The Jervell and Lange-Nielsen syndrome (JLNS) is a rare autosomal recessive form of the long QT syndrome linked with a profound hearing loss caused by mutations affecting both alleles of either the KCNQ1 or the KCNE1 gene. We carried out a mutant screening of the KCNQ1 and KCNE1 genes in a clinical diagnosed German family with JLNS. Family members were examined by SSCP analysis and RT-PCR and amplified products were characterized by DNA sequence analysis. We identified a splice donor mutation of exon 1 in the KCNQ1 gene (G477+1A). Analysis of lymphocyte RNA by RT-PCR revealed that two symptomatic patients, homozygous for the mutant allele, exclusively produce KCNQ1 transcripts lacking exon 1 leading to a frame shift that introduced a premature termination codon at exon 4. Mutant subunits, functionally characterized in Xenpous oocytes, were unable to form homomeric channels but strongly reduced I Ks in vitro (mutant isoform 1 and 2 by 62% and 86%, respectively), a fact supposed to lead to severely affected heterozygous individuals. However, individuals heterozygous for the mutant allele exhibit an asymptomatic cardiac phenotype. Thus, the observed dominant-negative effect of mutant subunits in vitro is absent in vivo leaving heterozygous individuals unaffected. These data suggest mechanisms that prevent production of truncated KCNQ1 channel subunits in cardiomyocytes of individuals heterozygous for the mutant allele.
The Jervell and Lange-Nielsen syndrome (JLNS) is a rare autosomal recessive form of the long QT syndrome linked with a profound hearing loss caused by mutations affecting both alleles of either the KCNQ1 or the KCNE1 gene. We carried out a mutant screening of the KCNQ1 and KCNE1 genes in a clinical diagnosed German family with JLNS. Family members were examined by SSCP analysis and RT-PCR and amplified products were characterized by DNA sequence analysis. We identified a splice donor mutation of exon 1 in the KCNQ1 gene (G477+1A). Analysis of lymphocyte RNA by RT-PCR revealed that two symptomatic patients, homozygous for the mutant allele, exclusively produce KCNQ1 transcripts lacking exon 1 leading to a frame shift that introduced a premature termination codon at exon 4. Mutant subunits, functionally characterized in Xenpous oocytes, were unable to form homomeric channels but strongly reduced I Ks in vitro (mutant isoform 1 and 2 by 62% and 86%, respectively), a fact supposed to lead to severely affected heterozygous individuals. However, individuals heterozygous for the mutant allele exhibit an asymptomatic cardiac phenotype. Thus, the observed dominant-negative effect of mutant subunits in vitro is absent in vivo leaving heterozygous individuals unaffected. These data suggest mechanisms that prevent production of truncated KCNQ1 channel subunits in cardiomyocytes of individuals heterozygous for the mutant allele. The progress of human genetics has been crucial in determining the correlation of ion channel genes and ventricular arrhythmias. Mutations in the potassium channel genes KCNQ1 (LQT1), KCNH2 (LQT2), KCNE1 (LQT5) and KCNE2 (LQT6) have been linked with different subtypes of the long QT syndrome (1) (2) (3) (4) . The KCNQ1 gene encoded pore forming α-subunit and the KCNE1 gene encoded ß-subunit coassemble to form the slowly activating delayed rectifier potassium current (I Ks ) channel involved in repolarisation of the cardiac action potential (5, 6) . Mutations in both genes cause two congenital forms of the long QT syndrome, the autosomal-dominant Romano-Ward syndrome (RWS) characterized by prolonged cardiac repolarisation, cardiac arrhythmias and a high risk of sudden death (7) or the JLNS characterized by a congenital bilateral deafness associated with a QT prolongation on the electrocardiogram (ECG), recurrent syncopes, seizures and sudden death due to ventricular arrhythmias of the torsades de pointes type (8) . Unlike the RWS, the JLNS is caused by mutations affecting both alleles of the KCNQ1 or the KCNE1 gene (8, 9) . The majority of JLNS cases, however, are caused by KCNQ1 mutations that affect the structure of the subunits by introduction of translation stop codons yielding premature subunits and by missense mutations discussed to prevent assembly of I Ks channels (10-13).
We report a JLNS causing mutation of the KCNQ1 gene and show that at the border from exon 1 to intron 1 the position of the first intronic nucleotide, nearly always a guanine followed by a thymidine (14) , is replaced by adenine (G477+1A). This altered splice donor site is associated with a splice error. Skipping of exon 1 caused a frame shift that introduces a premature translational termination codon leading to the expression of truncated KCNQ1 potassium channel subunits. Functional analysis in Xenopus oocytes revealed that mutant subunits exert strong dominant-negative effects on I Ks currents supposed to induce JLNS symptoms in heterozygous individuals. These results are really exciting, because a variety of clinical manifestations has been linked to the heterozygous state of mutations at the splice donor site of exon 1 (G477+1A; G477+5A; G477+5C; this work, [15] [16] [17] [18] [19] . Due to the fact that most heterozygous individuals lack cardiac deficits, molecular mechanisms might exist (20, 21) that abolish suppression of I Ks currents by mutant KCNQ1 subunits.
EXPERIMENTAL PROCEDURES
Subjects -Our study is based on a threegeneration family of German origin comprising two symptomatic individuals affected by profound sensorineural deafness and a prolonged QTc interval (Fig. 1) . The subjects of this family underwent detailed clinical and cardiovascular examination, including a 12-lead ECG. The QT intervals were measured on the ECG in lead II or V5 and corrected for heart rate by the use of the Bazett formula. The investigation conforms with the principles outlined in the Declaration of Helsinki. Mutation analysis -Genomic DNA was extracted from blood samples of the available family members using the genomic DNA extraction kit (Qiagen) in accordance with manufacturer`s protocol. The PCR primers (22) W33 (ATGGGAGAGGCCGTGATGCTGAC) and W34 (ATCCAGCCATGCCCTCAGATGC) were used to amplify exon 1 of the human KCNQ1 gene. The PCR reaction mix contained 50ng DNA as template, 25pM of each primer, 200µM 4-dNTP, 1 U Thermus aquaticus DNA polymerase (Amersham, Germany), 10mM TrisHCl, pH 8.3, at room temperature, 50mM KCl, and 1.5mM MgCl 2 in a volume of 50µl. The DNA was denatured by exposing to 95°C for 5 min, and then amplified for 35 cycles in a Hybaid Omnigene Temperature Cycler. Each cycle consisted of a denaturation step at 95°C for 15 s, an annealing step at 61°C for 15s, and an extension step at 72°C for 45s. For single strand conformation polymorphism (SSCP) analysis, PCR products were separated on a 5-15% polyacrylamide gradient gel using a Multiphor II Electrophoresis system and visualized by silver staining (23) .
RT-PCR of RNA isolated from whole blood cells -Total RNA (~10 µg) was isolated out of 2.5 ml whole blood (PAXgene kit, Qiagen, Germany) and 1 µg was reverse transcribed using Superscript II reverse transcriptase (Gibco BRL, Germany) and random hexamer primer. The PCR primers KCNQ1-433 (GCCGCGTCTAC AACTTCCTC) and LQT201 (24) (ATGGAAA TGGGCTTCCGGGCAAAGCGC) were applied to amplify a KCNQ1-isoform 1 wild type cDNA fragment of 277bp respectively the mutant isoform 1 derived cDNA fragment of 186bp lacking exon 1. Following denaturation at 95°C for 5 minutes, 35 PCR cycles were performed on a Temperature Cycler (MWG, Germany) with a 1 minute denaturation step at 95°C, a 1 minute annealing step at 58°C, and a 1 minute extension step at 72°C. Normal and aberrant PCR products were subcloned and characterized by DNA sequence analysis of both strands (23 (20-22°C) . No leak subtraction was done during the experiments. All data are expressed as mean ± standard error of the mean (SEM) unless otherwise specified (25) . Subunit expression and immunohistochemistry -COS-1 cells (2x10 4 ) were grown on fibronectin coated cover slips in DMEM with Penicillin /Streptomycin, Glutamine, Sodium pyruvate (GIBCO, Germany) and FCS (Pan Biotech, Germany) at 37°C in 10% CO 2 . Cells were transiently transfected using Effectene® transfection reagent (Qiagen) and 0.2µg of plasmid DNA encoding wildtype or mutant KCNQ1 subunits FLAG-tagged at their Cterminus. Plasmids were generated by cloning of the appropriate DNA fragments into the pFLAG-CMV-5.1 vector (Sigma, Germany). 24h after transfection, cells were washed in PBS and nitrogen-fixed according to Neuhaus et al., (26) . Anti-FLAG antibody staining was performed at 4°C over night using a 1:1000 dilution of the affinity-purified monoclonal anti-FLAG antibody (Sigma, Germany) in 2% BSA/PBS. After washing with PBS (2 x 30min), cover slips were incubated for over night in 2% BSA/PBS at 4°C with a 1:500 diluted secondary antibody (MFP 488 goat anti-mouse IgG, Molecular Probes, USA) in 2% BSA/PBS. Cover slips were washed in PBS (2 x 30 min) and mounted in Citifluor AF2 (Plano, Germany).
RESULTS
Clinical and genetic characterization -The index patient, a now 17 year old boy, was diagnosed with congenital deafness at the age of 10 months. Further diagnosis revealed a prolonged QTc of 0.56s ( Fig. 1 , patient III.2, closed square). Treatment with propranolol was started. Because of side effects the dosage had been reduced. In the following years recurrent syncopes occurred in association with physical and emotional stress especially during swimming. Consequently, the propranolol dosage was readjusted to 3mg/kg/day. Since the age of five no more syncopal episodes appeared under treatment with propranolol. The index patient has a four years younger sister which also was diagnosed of congenital deafness and prolonged QTc interval of 0.52s (Fig. 1, patient  III.1, closed circle) . Treatment with propranolol at a dosage of 3mg/kg/day was started at the age of 6 month. Recurrent syncopes occurred in the last three years in association with physical stress especially during swimming. Because of recurrent events under an adequate dosage of propranolol, implantation of a cardioverter defibrillator (ICD) was strongly advised, but has been refused by the family. Until today no episodes of cardiac arrest occurred. The family history revealed no other family members with congenital deafness, recurrent syncope or sudden death. ECG and clinical history of the parents, the mother's sister and the mother's parents were inconspicuous. The uncle of the index patient (Fig. 1, II.1 ) has a history of epileptic seizures, an ECG could not be obtained. The index patient's parents are distantly related because ancestral consanguinity occurred five generations ago. Genetic analysis -We focused our analysis on the JLNS candidate genes encoding the potassium channel subunits KCNQ1 and KCNE1 which together form the I Ks channel (5, 6) . Exon sequences of both genes were assayed by PCR of genomic DNA extracted from blood samples of all family members followed by SSCP analysis (23) . Evaluation of the intronless KCNE1 gene revealed no abnormalities in the corresponding sequence and allowed us to exclude the ß-subunit encoding gene as the cause of the dysfunction. Subsequently, SSCP analysis of PCR products was focused on the pore forming α-subunit encoding gene KCNQ1. The pattern of exon 1-derived PCR products of mutated carrier appeared disordered compared to healthy individuals and symptomatic subjects with three abnormal SSCP bands (Fig. 2A, In order to identify the mutation underlying the altered migration pattern, DNA sequence analysis of exon 1-derived PCR products of the family members was performed on both strands and revealed a single nucleotide change. Due to a guanine (G) to adenine (A) transition at the exon 1 (upper letter) intron 1 (lower letter) border of the KCNQ1 gene (TGGATGgtacgt >> TGGATGatacgt), one of the most conserved nucleotides at the splice donor sequence (14) is altered in individuals carrying the mutated allele. Both symptomatic patients appeared homozygous for the observed replacement, whereas parents, paternal uncle and maternal grandfather appeared heterozygous (Fig. 2B) . Altered transcription in KCNQ1 mutant carriers -Expression analysis was performed using cDNA fragments generated by RT-PCR of total RNA from blood cells (lymphocytes) of healthy and affected individuals. As expected from the KCNQ1 mRNA sequence (27) , in healthy individuals primer KCNQ1-433 and LQT-201 exclusively amplified a 277bp KCNQ1 cDNA fragment (Fig. 2C, lane I.2) . Corresponding to the altered splice donor site, heterozygous family members produce two different KCNQ1 cDNA fragments, the 277bp cDNA fragment of the wild type allele and a shorter 186bp cDNA fragment of the mutant allele (Fig. 2C, (Fig.  2C, lane III.1, III.2) . DNA sequence analysis showed that heterozygous individuals produce a normal spliced wild type KCNQ1 transcript and an alternative spliced mutant KCNQ1 transcript lacking exon 1. The JLNS patients selectively produce transcripts missing exon 1 (Fig. 2D) . It is important to note that the human heart expresses two different KCNQ1-isoforms, the wild type KCNQ1 subunit transcript isoform 1 (embl: AF000571) encoding 676 amino acids (27) and an alternative spliced transcript, KCNQ1-isoform 2 (embl: NM_181798), encoding a KCNQ1 subunit lacking the Nterminal 127 amino acids (24) (Fig. 3) . Consequently, altered transcripts encoding both isoforms were expected to appear in lymphocytes of mutant carriers (Fig. 3) . However, RT-PCR analysis of total RNA of lymphocytes detected isoform 1 but could not detect isoform 2 transcripts. Composition of mutant KCNQ1 isoforms -In the heart both isoforms are transcribed (24, 27) . Deletion of KCNQ1 exon 1 yielded mutant isoform 1 transcripts (KCNQ1-iso1M) composed of exon 1a fused to exon 2 to 15 and mutant isoform 2 transcripts (KCNQ1-iso2M) composed of exon 1b fused to exon 2 to 15 (Fig.  3) . Skipping of exon 1 generates a frame shift that introduced a premature termination codon at exon 4. Accordingly, mutant isoform 1 subunits consist of the exon 1a encoded N-terminal 129 amino acids (aa) fused to 76 aa encoded by the introduced frameshift whereas mutant isoform 2 subunits were composed of the exon 1b encoded N-terminal 2 aa fused to the same, frame shift provided 76 aa (Fig. 3) . Thus, homozygous and heterozygous carrier of the JLNS causing mutation express truncated KCNQ1 subunits of either 205 aa (KCNQ1-iso1M), or 78 aa (KCNQ1-iso2M) that have little similarity to KCNQ1 potassium channel subunits present in healthy individuals. Functional properties of mutant KCNQ1 subunits -First, we analysed homomeric channels formed by wild type KCNQ1-iso1 subunits or mutant KCNQ1-iso1M and KCNQ1-iso2M subunits following injection of cRNA (1.8 ng each) into Xenopus oocytes. Currents were elicited by 2-s steps to potentials ranging from -60 to 120mV (increment 20mV), and tail currents were recorded at -40mV. The holding potential was -80mV, and pulses were applied at a frequency of 0.2Hz during all electrophysiological measurements (25) . Under these conditions, expression of KCNQ1-iso1 subunits produced channels with a mean tail current amplitude of 0.98±0.092µA (n=20) (Fig.  4A, column 1) , whereas oocytes expressing mutant KCNQ1-iso1M (Fig. 4A, column 2) or KCNQ1-iso2M subunits (Fig. 4A, column 7 ) produced no currents (KCNQ1-iso1M: 0.041±0.01µA, n=20; KCNQ1-iso2M: 0.037±0.011µA, n=20) comparable to uninjected oocytes (Fig. 4A, column 4) . Mutant KCNQ1 subunits affect KCNQ1-iso1 channels -To further investigate the functional consequences of this JLNS mutation, we determined the ability of the mutant subunits to influence wildtype KCNQ1-iso1 currents. In coexpression experiments the same amount (1.8 ng) of KCNQ1-iso1M or KCNQ1-iso2M cRNA was injected with equal amounts of KCNQ1-iso1 cRNA and the resulting currents were compared with KCNQ1-iso1 currents. KCNQ1-iso1M subunits caused little changes (5%) with currents similar to KCNQ1-iso1 currents (0.932±0.079µA, n=20; Fig. 4A, column 3) . Surprisingly, mutant KCNQ1-iso2M subunits reacted differently and caused a pronounced reduction (45%) of KCNQ1-iso1 currents to 0.543±0.055µA (n=20) (Fig. 4A, column 6) , an attribute basically associated to dominantnegative RWS-type, but absent from JLNS-type mutations (12) . KCNQ1 mutant isoforms cause dominantnegative suppression of I Ks -In order to examine whether the truncated mutant KCNQ1 subunits interfere with I Ks , we measured Xenopus oocytes injected with equal amounts (1.8ng) of KCNQ1-iso1, KCNQ1-iso2, KCNQ1-iso1M or KCNQ1-iso2M cRNA together with (1.8ng) KCNE1 cRNA. The combination of KCNQ1-iso1 and KCNE1 subunits induced outward potassium currents with properties nearly identical to native cardiac I Ks with an average tail amplitude of 3.58 ± 0.5µA (n = 20, Fig. 4B and E, column 1), whereas co-expression of KCNQ1-iso2 with KCNE1 displayed very low I Ks amplitudes of 0.02 ± 0.02µA (Fig. 4E, column 2 ) not different from uninjected control oocytes (Fig. 4E,  column 6 ). In contrast, expression of KCNE1 ß-subunits alone produced small I Ks amplitudes of 0.31 ± 0.04µA (Fig. 4E , column 5) thought to be generated by interaction with endogenous Xenopus KCNQ1 subunits (6) . Co-expression of mutant KCNQ1-iso1M with KCNE1 exhibited tail currents of 0.17 ± 0.02µA ( Fig. 4D and E, column 3) representing only 5% of the nonmutant isoform 1/KCNE1 current. Therefore the mutant protein KCNQ1-iso1M failed to produce a relevant potassium current when coinjected with KCNE1. Similarly, mutant isoform 2 encoded subunits (KCNQ1-iso2M) were not able to produce potassium currents in combination with KCNE1 subunits (0.141 ± 0.02µA) (Fig. 4E, column 4) . Currents smaller than KCNE1 produced currents implied an interaction of mutant KCNQ1 subunits with channels composed of endogenous Xenopus KCNQ1 and KCNE 1 subunits. To investigate the effect of mutant KCNQ1 subunits on I Ks , we injected KCNQ1 and KCNE1 cRNA (1.8ng each) together with 1.8ng cRNA encoding mutant isoform 1 or isoform 2 subunits into Xenopus oocytes. In the presence of KCNQ1-iso1M subunits, I Ks were suppressed in a dominant-negative fashion by approximately 62% producing a tail current of 1.36 ± 0.28µA ( Fig. 4C and E, column 7) . Coexpression of KCNQ1-iso1 with mutant KCNQ1-iso2M and KCNE1 suppressed I Ks even stronger (86%) and gave a significantly lower tail current of 0.49 ± 0.1µA (Fig. 4E, column 8) . KCNQ1 wildtype and mutant subunit expression in COS-1 cells -In order to study whether mutant subunits show differences in abundance, cellular distribution and cellular localisation, transient transfections of COS-1 cells were performed to express mutant and wildtype KCNQ1 subunits that were FLAG-tagged at their C-terminus. Antibody staining using anti-FLAG antibodies showed that mutant and wildtype subunits were distributed in a similar pattern (Fig. 5A-C) , indicating that the marked truncation of the mutant subunits did neither compromise their cellular location nor their transport to the cell surface. This is in line with the functional analysis of wildtype and mutant channels in Xenopus oocytes.
DISCUSSION
The JLNS is a rare autosomal recessive inherited disease characterized by a profound hearing loss associated with QT-prolongation in ECG, syncopal attacks, seizures and sudden death from ventricular arrhythmias. JLNS associated mutations have been identified in the pore forming α-subunit KCNQ1 and in the auxiliary ß-subunit KCNE1 (1, 2, 8-13) which coassemble to form I Ks in the heart (5, 6). To date, several frame shift or truncation mutations generated by altered splicing, deletion or insertion have been reported to be responsible for the majority of the JLNS cases caused by homozygous as well as compound heterozygous mutations of the KCNQ1 or the KCNE1 gene (2, 8-13, 15-19, 27-31) .
With this study we characterized the structural and functional features of a mutation at the splice donor site of the KCNQ1 gene's exon 1 (G477+1A) in a German family with JLNS. Mutant carriers produce KCNQ1 transcripts lacking exon 1 leading to a frame shift. By this, a premature stop codon is introduced causing the expression of truncated KCNQ1 subunits. Thus, the JLNS patients in this family selectively produce altered transcripts, leading to mutant isoform 1 subunits (KCNQ1-iso1M) composed of 205 aa comprising one third of the first transmembrane segment (129 aa encoded by exon 1a fused to 76 aa encoded by the frame shift) and mutant isoform 2 derived subunits (KCNQ1-iso2M) composed of 78 aa (2 aa encoded by exon 1b fused to the frame shift provided 76 aa) lacking any KCNQ1 transmembrane segment. In consequence, KCNQ1 wildtype and mutant subunits show little structural similarities. In agreement with these findings, mutant subunits encoded by isoform 1 or 2, KCNQ1-iso1M respectively KCNQ1-iso2M, were unable to form homomeric potassium channels. Moreover, KCNQ1-iso1M subunits failed to affect the formation of homomeric KCNQ1-iso1 channels, whereas the much smaller KCNQ1-iso2M subunits, when co-expressed in Xenopus oocytes, reduced KCNQ1-iso1 currents to 46%, a feature well assigned to RWS-type mutations and used to distinguish RWS from JLNS mutations (12) . Of even greater importance is that in coexpression experiments with KCNE1, mutant KCNQ1 subunits showed the ability to affect I Ks currents in a dominant-negative mode with current reduction to 38% (KCNQ1-iso1M) respectively 14% (KCNQ1-iso2M).
Thus, mutant subunits confer properties more related to RWS-than to JLNS-associated KCNQ1 mutations (12, 27) and these features may explain, at least in part, the variety of clinical manifestations in heterozygous carriers associated with KCNQ1 transcripts lacking exon 1.
Heterozygous individuals appear asymptomatic with normal QTc intervalls (This  report; 17), asymptomatic with QTc prolongation (15, 17) , as RWS patients (15, 19) and as compound JLNS (17) or compound RWS (18) . In respect of such a discrepancy, expression of mutant KCNQ1 subunits and hence their ability to influence I Ks in the heart might be regulated on an individual level.
A lack of I Ks reduction in healthy heterozygous individuals implies mechanisms that in cardiomyocytes prevent the potentially noxious influence of the truncated subunits. In this view, the abundance and distribution of the truncated subunits in cardiaomyocytes could be affected or, alternatively, the transport of the truncated subunits to the cell surface could be impaired leading to the absence of I Ks channels composed of mutant and wildtype subunits. Interestingly, anti-FLAG antibody staining of COS-1 cells transiently transfected with plasmids encoding the FLAG-tagged mutant and wildtype subunits revealed a similar expression pattern with mutant and wildtype subunits indistinguishably distributed. In combination with their functional analysis in Xenopus oocytes, these data suggested that independent on their truncation, mutant subunits were transported to the cell surface, like wildtype subunits. Apart from these features, we do not know whether the stability of the truncated subunits in cardiomyocytes differs from the stability of wildtype subunits, yet an additional fact that could explain the presence of healthy heterozygous individuals.
On the other hand, a recently described mRNA surveillance system, the nonsense mediated decay which rapidly degrades mutant transcripts carrying a premature stop codon (20, 21) , might offer an alternative explanation how cardiomyocytes abolish or reduce the dominantnegative effect required to establish the recessive nature of JLNS in heterozygous carriers with KCNQ1 transcripts lacking exon 1. 3 . The exon arrangement of the human KCNQ1 gene yielding the isoforms of wildtype and mutant alleles. Wildtype isoform transcripts are composed of exons 1a, 1, 2-15 (isoform1) encoding 676 amino acids (aa), respectively, exons 1b, 1, 2-15 (isoform 2) encoding 549 aa, while the mutant isoforms consists of exon 1a, 2-15 (mutant isoform 1) encoding a truncated subunit of 205 aa and exon 1b, 2-15 (mutant isoform 2) encoding 78 aa. The mutant KCNQ1 isoform 1 encoded polypeptide is composed of 129 aa of exon 1a, representing the N-terminal region including one third of the first transmembrane segment (S1) fused to 76 aa provided by the introduced frameshift. The mutant KCNQ1 isoform 2 encoded polypeptide is composed of 2 aa of exon 1b fused to the frameshift derived 76 aa. The deleted exon 1 in mutated KCNQ1-isoforms is marked by an asterisk. Arrows indicate the frameshift introduced termination codon (rhombus) at exon 4 in the KCNQ1 gene. E = exon. Fig. 4 . Heterologous expression of KCNQ1 isoforms, mutant subunits and KCNE1 in Xenopus oocytes. Wildtype: KCNQ1-iso1 = Iso1, KCNQ1-iso2 = Iso2. Mutant: KCNQ1-iso1M = IsoM1, KCNQ1-iso2M = IsoM2. A, Mean peak tail current amplitudes obtained from two batches (n=20). KCNQ1-iso1M, -iso2M, and -iso2 exhibited currents not different from (uninjected) control. Coexpression of KCNQ1-iso1 + KCNQ1-iso1M produced currents not significantly different from KCNQ1-iso1 currents, while coexpression of KCNQ1-iso1 with KCNQ1-iso2M reduced current to 55% of KCNQ1-iso1 currents. B, Coexpression of KCNQ1-iso1 with KCNE1 resulted in K + -currents very similar to I Ks . C, Coexpression of KCNQ1-iso1 with KCNE1 and mutant KCNQ1-iso1M yielded I Ks amplitudes reduced by approximately 62%, indicating a dominant-negative effect of the mutant polypeptide. D, Expression of mutant KCNQ1-iso1M together with KCNE1 produced very low currents. Voltage protocol in B-D: holding potential -80mV, test pulse -60 to 120mV (2s) in 20mV increments, return pulse constant -40mV (2s). E, Expression of JLNS mutant subunits KCNQ1-iso1M and -iso2M in combination with the ß-subunit KCNE1 produced very low current amplitudes. In contrast to I Ks produced by channels composed of KCNQ1-iso1 and KCNE1 subunits, expression of mutant KCNQ1 subunits with KCNE1 and KCNQ1-iso1 subunits reduced I Ks in a dominant-negativ fashion to 38% (KCNQ1-iso1M) and 14% (KCNQ1-iso2M). Fig. 5 . Cellular distribution of KCNQ1 wildtype and mutant subunits. Confocal images of COS-1 cell transiently transfected with FLAG-tagged constructs encoding A, KCNQ1-iso1-FLAG, B, mutant KCNQ1-iso1-FLAG and C, mutant KCNQ1-iso2-FLAG. Anti-FLAG antibody staining revealed a similar and even distribution of mutant and wildtype subunits in COS-1 cells indicating that the truncation of the mutant subunits has no influence on their transport and cellular location. 
